Rationale and strategy for thalidomide as a BACE 1 inhibitor for a phase II randomized clinical trial in mild-to-moderate Alzheimer's disease

✍ Scribed by Sabbagh, Marwan N.; Nural, Hikmet; He, Ping; Sirrel, Sherye; Belden, Christine; Liebsack, Carolyn; Li, Rena; Shen, Yong

• Book ID: 123027697
• Publisher: Elsevier Science
• Year: 2010
• Tongue: English
• Weight: 43 KB
• Volume: 6
• Category: Article
• ISSN: 1552-5260
• DOI: 10.1016/j.jalz.2010.05.1996